ReviewFrontiers in immunology2021

Biomarkers for Chimeric Antigen Receptor T Cell Therapy in Acute Lymphoblastic Leukemia: Prospects for Personalized Management and Prognostic Prediction.

Ruimin Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.